Page 31 - Sohini Das

States gear up as Covid surges: Big hospitals ready, smaller ones concerned

States have started issuing fresh guidelines as cases continue to rise

Shot stories: Meet Bharat Biotech's Krishna Ella, the man behind Covaxin

As the pandemic raged, India developed its own vaccine. Those weren't easy days, Ella, the man behind Covaxin, tells Sohini Das

We have developed an 80% biodegradable tyre: JK Tyre CMD Singhania

Average selling price of tyres will 'slightly move up', he says in interview about where industry is headed

OEM, dealers to play Santa during year-end for EV passenger vehicles

Carmakers, dealers offering discounts up to Rs 4 lakh

Up & down the job rollercoaster: Highs for aviation & pharma, lows for IT

The game flipped in the second half of 2022, and in 2023, it has decisively turned in the favour of employers - more talent is now chasing fewer active IT jobs

JB Chemicals buys opthalmology brands from Novartis for Rs 964 crore

JB Chemicals and Pharmaceuticals shall offer employment to the impacted associates working on this portfolio, it said today. JB Chemicals shares ended on BSE at Rs 1466 apiece, down marginally

Why Maruti remains big on small cars, even when India shifts to larger cars

MSIL, the quintessential maker of small cars, has not fallen short of taking a bet on small hatchbacks even when there seems to be a structural shift in the Indian market towards larger cars

India on alert as JN.1 Covid variant emerges, active cases surge to 1,828

MoH issues advisories to states. Karnataka brings back mask rule for senior citizens after Kerala sees spike in cases

Zydus Noveltech dissolved for not generating 'meaningful revenue'

It had nil operating revenue and a net worth of Rs 10 crore as of March 31, 2023

Kerala reports 4 Covid deaths as cases spike, MoHFW conducts mock drill

Nothing to worry about, says state health minister

Hospitals see 7-8% surge in patient footfall, new investments in 2023

Jose told Business Standard that investments in medical equipment and increasing bed capacities have picked up in 2023 after a hiatus during the Covid19 period

PharmEasy bags Rs 1.3K cr from Pai; Rs 3.5K cr rights issue oversubscribed

Besides Pai's commitment, PharmEasy raised the remaining Rs 2,200 crore from existing shareholders

Investing half a billion dollar in our generics business: Biocon MD & CEO

Debt-reduction plans are progressing a tad slowly, said Siddharth Mittal

Indian companies likely to garner up to 50% USFDA nod share in 2023

Companies may get up to 375 ANDA approvals in 2023, more than last year's 355

The new @UTO Motto: Why makers of 2-wheelers, cars are embracing ecommerce

Dealerships remain the primary point of sale, but this is a fast-evolving scenario, catalysed by both Amazon as well as Flipkart introducing the auto category last year

M&M, investors to put Rs 875 cr in Classic Legends over next 2-3 years

CLPL revived heritage brands like Yezdi and Jawa. However, it has been able to gain significant market share in the premium segment, which is still largely dominated by Eicher Motors' Royal Enfield

Loss of patents: Indian pharma companies gain, shows PharmaTrac data

While MNCs posted a 5 per cent five-year compound annual growth rate (CAGR) in the chronic segment, Indian pharma companies have recorded a 9 per cent 5-year CAGR

Passenger vehicles cruise to a record, small car sales skid 21% in Nov

Rajesh Menon, Director General of SIAM, said, "Passenger Vehicles posted the highest ever sales in November 2023 of 3.34 lakh units, albeit with a growth rate of 3.7 per cent

Kinetic's high-speed e-scooter Zulu comes with battery subscription plan

The battery subscription model is claimed to have reduced the acquisition cost by over 35 per cent and offers significant savings on running costs

FAME subsidy needed for 3-5 years: Kinetic Green founder and CEO

Motwani spoke about the need to have subsidies under Faster Adoption and Manufacturing of (Hybrid &) Electric Vehicles (FAME) for three-five year